J.P. Morgan Remains a Sell on Shanghai Junshi Biosciences Co., Ltd. Class H (1877)
According to TipRanks, Huang is a 5-star analyst with an average return of 36.9% and a 67.57% success rate. Huang covers the Healthcare sector, focusing on stocks such as Innovent Biologics, Wuxi Biologics (Cayman), and Hangzhou Tigermed Consulting Co., Ltd. Class H. The word on The Street in general, suggests a Hold analyst consensus rating for Shanghai Junshi Biosciences Co., Ltd. Class H with a HK$30.56 average price target.
According to TipRanks, Huang is a 5-star analyst with an average return of 36.9% and a 67.57% success rate. Huang covers the Healthcare sector, focusing on stocks such as Innovent Biologics, Wuxi Biologics (Cayman), and Hangzhou Tigermed Consulting Co., Ltd. Class H.
The word on The Street in general, suggests a Hold analyst consensus rating for Shanghai Junshi Biosciences Co., Ltd. Class H with a HK$30.56 average price target.
